Search - tctmd.com

Displaying 601 - 620 of 2553

Sort: Relevancy | Date

Presentation ARCH 2022

Meet the Experts: Case Review

Presenter: Mark Gdowski

April 23, 2022

Presentation ARCH 2022

Meet the Experts Case

Presenter: Chien-Jung Lin

April 23, 2022

Presentation ARCH 2022

Anesthesia Update: Dealing with High-Risk Pulmonary Hypertension Patients

Presenter: Jonathan Zoller

April 23, 2022

Presentation ARCH 2022

Optimizing Results in Unstable Patients With Complex Disease Requiring High Risk PCI

Presenter: John M. Lasala

April 23, 2022

Presentation ARCH 2022

Acute PE Therapies: A Case Based Discussion

Presenter: George S. Chrysant

April 23, 2022

Presentation ARCH 2022

Top Vascular Trials of the Past Three Years

Presenter: Sahil A. Parikh

April 23, 2022

Presentation ARCH 2022

Top Trials of the Past Year: Advanced Revascularization

Presenter: David G. Rizik

April 23, 2022

Presentation ARCH 2022

Use of Imaging in Calcified and Fibrotic Lesions

Presenter: Marc Sintek

April 23, 2022

Presentation ARCH 2022

Calcium Management Strategies: From Atherectomy to IVL

Presenter: Anish J. Thomas

April 23, 2022

News Daily News

Timely PCI May Outweigh Hospital Factors for ACS Patients With Cardiogenic Shock

Caitlin E. Cox

April 18, 2022

News Daily News

Revascularization’s Benefits in HFrEF Linked to Gains in LV Function

Caitlin E. Cox

April 15, 2022

News Conference News ACC 2022

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

Michael O'Riordan

April 13, 2022

News Conference News ACC 2022

POISE-3: Two Perioperative BP Strategies Give Similar Results in Noncardiac Surgery

Todd Neale

April 06, 2022

Presentation ACC 2022

Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial

Presenter: Duk-Woo Park

April 04, 2022

Presentation ACC 2022

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

Presenter: Michael J. Reardon

April 04, 2022

News Conference News ACC 2022

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Michael O'Riordan

April 04, 2022

News Conference News ACC 2022

Most Infected Cardiac Implanted Electronic Devices Not Removed Fast Enough

Michael O'Riordan

April 04, 2022

News Conference News ACC 2022

PACMAN-AMI: Positive Plaque Changes With Early Alirocumab Use in Acute MI

Todd Neale

April 03, 2022

News Conference News ACC 2022

Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term

Shelley Wood

April 03, 2022

News Conference News ACC 2022

Mavacamten Slashes Need for Septal Reduction in Obstructive HCM: VALOR-HCM

Yael L. Maxwell

April 02, 2022

Advertisement

Meet the Experts: Case Review

Meet the Experts Case

Anesthesia Update: Dealing with High-Risk Pulmonary Hypertension Patients

Optimizing Results in Unstable Patients With Complex Disease Requiring High Risk PCI

Acute PE Therapies: A Case Based Discussion

Top Vascular Trials of the Past Three Years

Top Trials of the Past Year: Advanced Revascularization

Use of Imaging in Calcified and Fibrotic Lesions

Calcium Management Strategies: From Atherectomy to IVL

Timely PCI May Outweigh Hospital Factors for ACS Patients With Cardiogenic Shock

Revascularization’s Benefits in HFrEF Linked to Gains in LV Function

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

POISE-3: Two Perioperative BP Strategies Give Similar Results in Noncardiac Surgery

Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Most Infected Cardiac Implanted Electronic Devices Not Removed Fast Enough

PACMAN-AMI: Positive Plaque Changes With Early Alirocumab Use in Acute MI

Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term

Mavacamten Slashes Need for Septal Reduction in Obstructive HCM: VALOR-HCM

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content